These emerging drugs , including Semaglutide , a similar compound, and Zaxig , represent a significant advancement in treating type 2 the condition and supporting weight loss . They function by imitating the body’s natural incretin GLP-1 , assisting to regulate blood levels and lower appetite . The drug has somewhat distinct properties and can be